The t(12;21) translocation resulting in the TEL-AML1 gene fusion is found in 25% of childhood B-cell precursor (BCP) acute lymphoblastic leukemias (ALL). Since TEL-AML1 has been reported to induce cell cycle retardation and thus may influence somatic recombination, we analyzed 214 TEL-AML1-positive ALL by PCR for rearrangements of the immunoglobulin (Ig) and T-cell receptor (TCR) genes. As a control group, 174 childhood BCP ALL without a TEL-AML1 were used. The majority of TEL-AML1-positive leukemias had a higher number of Ig/TCR rearrangements than control ALL. They also had a more mature immunogenotype characterized by their high frequency of complete IGH, IGK-Kde, and TCRG rearrangements. While IGK-Kde and TCRG were more frequently rearranged on both alleles at higher age, IGH and TCRD rearrangements decreased in their incidence along with a decrease in biallelic IGH rearrangements. This suggests that the recombination process continues in these leukemias leading to ongoing rearrangements and possibly also deletions of antigen receptor genes. We here provide first evidence that somatic recombination of antigen receptor genes is affected by the TEL-AML1 fusion, and that further age-related differences are probably caused by the longer latency period of the prenatally initiated TEL-AML1-positive leukemias in older children.
Introduction
The t (12;21) translocation is the most common chromosomal aberration observed in about 25% of B-cell precursor (BCP) acute lymphoblastic leukemias (ALL). 1 It results in the fusion of two critical regulators of hematopoiesis, the TEL gene on chromosome 12p13 and the AML1 gene on chromosome 21q22. 2, 3 The TEL-AML1 fusion gene defines a specific clinical subgroup of ALL in children aged between 1 and 10 years with B-precursor immunophenotype, nonhyperdiploid karyotype, and generally low-risk features. 4, 5 Like several other subgroups of pediatric ALL, the TEL-AML1-positive leukemia is initiated in utero. 6 This has been demonstrated by retrospective detection of the same leukemia clonespecific TEL-AML1 fusion sequence in identical twins and triplets, [7] [8] [9] and of clonotypic TEL-AML1 fusion sequences in the neonatal blood spots from singleton children with ALL. 10 The functional role of the TEL-AML1 fusion gene in the development of leukemia, however, is still poorly understood.
During early lymphoid development, cells recombine their antigen receptor genes. This process, called somatic recombination, is mediated by RAG proteins and is closely connected to the cell cycle. 11 In particular, RAG-2 has been found to accumulate preferentially in G0/G1 phase and to degrade at the G1-S transition. 12 In B cells, IGH is rearranged first, joining a D H to a J H segment on both alleles, followed by a V H to DJ H rearrangement on one of the two alleles. If this latter recombination is not productive, the other incomplete rearrangement undergoes further recombination. Upon expression of the immunoglobulin m (Igm) chain in the cytoplasm, Ig light chain genes start to rearrange. 13 In childhood BCP ALL, this hierarchical order of recombination is generally maintained.
14 Clonotypic IGH rearrangements are present in up to 90% of BCP ALL with a prevalence of complete VDJ H recombinations, but partial DJ H rearrangements are also found in about 20%. 15, 16 IGK-Kde rearrangements are less frequent and occur in about 50% of BCP ALL. 17 Crosslineage TCRG and incomplete TCRD rearrangements have been described in 40-70 and 50% of these leukemias, respectively. 18 Ig and TCR rearrangements not only serve as clonotypic markers for the leukemia but they may also provide important biological information. It has been shown that the types and/or characteristics of antigen receptor gene rearrangements in BCP ALL may vary with the patients' age, as well as with the genotype of the leukemia. [19] [20] [21] [22] [23] [24] [25] [26] Leukemia-specific chromosomal translocations lead to disruption of the structure and function of genes that play an essential role in normal hematopoiesis. This may also apply to the t(12;21)-positive leukemias since it has been reported thatwhile AML1 accelerates G1 to S progression -the fusion with TEL converts AML1 from an activator to a repressor of transcription leading to cell cycle retardation. 27, 28 This cell cycle retardation may influence the recombination of Ig/TCR genes and its effect might be seen in TEL-AML1-positive leukemias. Our analysis of clonotypic Ig/TCR rearrangements demonstrates a high incidence of rearrangements with mature features, which differs significantly from TEL-AML1-negative BCP ALL.
Materials and methods

Patients
For the study group, 214 patients with BCP ALL were selected by the presence of the t(12;21) chromosomal translocation, which was identified by FISH and/or RT-PCR-based detection of the TEL-AML1 gene fusion. The control group comprised 174 children with BCP ALL without a t(12;21), t(9;22) or t(4;11) translocation. Data on other genetic subtypes, for example hyperdiploidy and t(1;19) translocation, were not consistently available. All patients were enrolled in the ALL-BFM 2000, the AIEOP-ALL 2000, or the Dutch Childhood Leukemia Study Group (DCLSG) ALL-8 or ALL-9 protocol. The diagnosis of ALL was based on standard morphologic, cytochemical, and immunological criteria. All patient samples were obtained according to the informed consent guidelines of the local or national medical ethics committees.
Identification of PCR targets at diagnosis
Diagnostic bone marrow samples were analyzed for incomplete and complete IGH rearrangements, IGK-Kde, TCRD, and TCRG rearrangements. PCR amplification, heteroduplex analysis, and sequencing were performed as described previously. [29] [30] [31] The involved segments of IGH, IGK, TCRD, and TCRG gene rearrangements were identified by comparison with published germline sequences using the sequence alignment software (V-QUEST) from IMGT (http://imgt.cines.fr:8104/ 
Definition of mono-and oligoclonality
A leukemia was assumed to be monoclonal if the number of rearrangements detected by PCR was equal or less than two, that is not more than one rearrangement per allele, irrespective of the intensity of the PCR bands. Although weak bands are likely to represent minor subclones, their intensity was not taken into consideration, because rearrangements were identified by either gene family or member PCR with degenerated primers, making the quantification of PCR products unreliable. An oligoclonal disease was diagnosed if more than two rearrangements per gene were present. This principle of classification was used for the PCR-based study of clonotypic rearrangements assuming that no irregular rearrangement or germline configuration was present in addition to the detected rearrangements.
Statistical analyses
To assess differences in the number of rearrangements and to compare relative frequencies of gene rearrangements between TEL-AML1-positive and TEL-AML1-negative leukemias (ie the primary aims of the study), the Mantel-Haenszel test and the w 2 test were used, respectively. Exploratory data analysis was performed for all other evaluations. The age distribution of patients with TEL-AML1-positive and TEL-AML1-negative ALL was analyzed by the Kolmogorov-Smirnov Two Sample Test. Logistic regression models were used to analyze the impact of age on antigen receptor gene rearrangements for each patient group. In addition, age, TEL-AML1 positivity, immunophenotype, and the interaction between these variables were included in logistic regression models to study their impact on the incidence and the number of IGH, IGK-Kde, TCRD, and TCRG rearrangements. The statistical analysis regarded age as a continuous variable, while for the graphical illustration of the data age was categorized into different groups. P-values o0.05 were considered as statistically significant, and P-values o0.1 as a trend for statistical significance.
Results
TEL-AML1-positive ALL have a unique age and immunophenotype distribution
The study group comprised 214 children with a TEL-AML1-positive BCP ALL with a common precursor B (CD10 positive) and a pre-B cell (CyIgm positive) immunophenotype in 67 and 33%, respectively. The male to female ratio was 1:1 and the patients' median age at diagnosis was 4.6 years (range 1.4-17.2 years). The control group consisted of 174 children with a common ALL and pre-B ALL in 61 and 39%, respectively. The male to female ratio was 1:1.1, and the median age 4.8 years (range 1.1-17.6). The four centers included all patients who were enrolled in the respective treatment protocols during a certain period of time into this joint study. The study and control groups were similar in terms of overall evaluation of the studied parameters (immunophenotype of the leukemias, median age, and sex of the affected children). The majority of patients with TEL-AML1-positive ALL (86%) were between 2 and 10 years old, with a peak incidence at 3-6 years (48%), while the patients' age in the control group was more broadly distributed with fewer children in the age group of 3-6 years (36%) (Figure 1) . The difference in age distribution of study and control group showed a trend for significance (P ¼ 0.05, KolmogorovSmirnov Two Sample Test), while the median age of the children was not statistically different.
The incidence of the immunophenotypes of the leukemias in the study group (common ALL in 66.8% and pre-B ALL in 33.2%) was independent of the children's age. In the control group, however, the pre-B phenotype predominated over common ALL in the very young children (age o2 years, 76.5%, Po0.01, w 2 test) and decreased with higher age to reach a similar distribution as in the study group (common ALL in 64.3% and pre-B ALL in 35.7%).
High incidence of antigen receptor gene rearrangements in TEL-AML1-positive ALL
The total number of antigen receptor gene rearrangements per leukemia, as detected by PCR amplification, is shown in Table 1 .
Figure 1
Age distribution of children with TEL-AML1-positive and -negative leukemias.
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Although the leukemias from the study and the control group did not differ regarding their median number of rearrangements (4, range 0-11), TEL-AML1-positive ALL had significantly more rearrangements than control ALL (Po0.01, Mantel-Haenszel test). Only 28% of TEL-AML1-positive ALL had less than four rearrangements compared to 45% of the TEL-AML1-negative leukemias. In all, 57% of TEL-AML1-positive cases had four to six rearrangements, which differed from the TEL-AML1-negative cases (42%), whereas the incidence of more than six rearrangements per leukemia was similar in the study and the control group. This high number of clonotypic rearrangements in the study group was derived from a significantly higher incidence of IGK-Kde and TCRG rearrangements compared to controls, as summarized in Table 2 . The overall incidence of IGH rearrangements, irrespective of the type of rearrangement (incomplete DJ H or complete VDJ H ), was equally high in both groups as was the incidence of TCRD rearrangements.
Scarcity of DJ H rearrangements and high incidence of VDJ H rearrangements in TEL-AML1-positive ALL While the overall incidence of IGH rearrangements was equally high in both groups, there were differences in the distribution of incomplete (DJ H ) and complete (VDJ H ) rearrangements (Table 2) . Interestingly, DJ H rearrangements were extremely rare in TEL-AML1-positive leukemias compared to control cases, while VDJ H rearrangements did not differ between the study and the control group. Provided the situation in leukemias reflects the hierarchical order of IGH gene recombination in normal B cells, incomplete DJ H rearrangements occur on both alleles before a V H segment is joined to one of these two rearrangements. Only if this rearrangement is not potentially functional, a V H segment is also joined to the DJ H rearrangement on the second allele. Hence, the virtual absence of DJ H rearrangements in TEL-AML1-positive patients would imply a high incidence of biallelic VDJ H rearrangements. We therefore looked at the relation between mono-and biallelic recombinations and compared these data with those obtained from the control group (Table 2 ). In the study group, mono-and biallelic recombinations occurred with equal frequency, while in the control group biallelic rearrangements were significantly more common than monoallelic rearrangements. The difference between the study and the control group was not statistically significant. Thus, the scarcity of DJ H rearrangements in the study group was not counterbalanced by a higher incidence of biallelic VDJ H rearrangements.
TEL-AML1-positive ALL have frequent biallelic IGK-KDE and TCRG rearrangements, but monoallelic TCRD recombinations To evaluate whether the high incidence of antigen receptor gene rearrangements in TEL-AML1-positive patients would be combined with a higher number of biallelic rearrangements of a particular antigen receptor gene, we compared leukemias with one rearrangement with those that have two (or more) rearrangements (Table 2 ). In the study group, IGK-Kde and TCRG show a predominance of biallelic rearrangements, while in the control group monoallelic rearrangements dominate over biallelic recombinations. TCRD rearrangements occur more frequently on one allele than on both in both groups. This difference is statistically significant only in the study group (Po0.01, w 2 test). There are no statistical differences, however, when the study and control groups are compared.
Age-related variations of Ig/TCR rearrangements are restricted to the common BCP phenotype, but differ between TEL-AML1-positive and -negative ALL The age-related frequencies of Ig/TCR rearrangements in the study and the control group are illustrated in Figure 2 . For statistical evaluation, a logistic regression analysis was performed to test the influence of TEL-AML1, age, and the interaction of these two variables on the incidence of antigen receptor gene rearrangements. As shown before, TEL-AML1 as well as the interaction between TEL-AML1 and age does not have a significant influence, whereas age alone has a significant impact on the incidence of IGH rearrangements (OR ¼ 0.88, Po0.01; the odds of having an IGH rearrangement is 0.88-fold as likely at each increasing year of age with regard to the younger age). There is also a general influence of age on the incidence of biallelic IGH rearrangements, which results in a decrease of rearrangements on both alleles with higher age. This difference is more pronounced in the study group (OR ¼ 0.93, P ¼ 0.04) than in the control group (OR ¼ 0.97, P ¼ 0.47), but is not statistically different between the study and the control group. As for the incidence of IGK-Kde rearrangements, there is a significant difference between the study and the control group (OR ¼ 2.8, Po0.01), but no influence by age (OR ¼ 1.0, Table 1 Number of antigen receptor gene rearrangements per ALL
TEL-AML1
No. of rearrangements per ALL Ig/TCR rearrangements in TEL-AML1-positive ALL S Hübner et al P ¼ 0.59). There is, however, a trend by the interaction of TEL-AML1 and age (OR ¼ 0.9, P ¼ 0.08). The number of rearranged IGK-Kde alleles does not change according to age in both groups. The incidence of TCRD rearrangements, but not the number of rearranged TCRD alleles, decreases with age in both groups (OR ¼ 0.87, P ¼ 0.01), but is more distinct in the TEL-AML1-positive group. There is a significant difference regarding the incidence of TCRG rearrangements between the TEL-AML1-positive and -negative group (OR ¼ 2.0, Po0.01), with a significant influence by age (OR ¼ 1.07, P ¼ 0.03) that is not statistically different between the TEL-AML1-positive and -negative group. The age-related difference of biallelic TCRG recombination between the study and the control group shows a trend (OR ¼ 1.1, P ¼ 0.08), which is also seen in the interaction with TEL-AML1 positivity (OR ¼ 1.1, P ¼ 0.06). Next, we were interested in whether the maturation stage of the leukemia (common BCP vs pre-B phenotype) has an effect on antigen receptor gene rearrangements. While no significant differences of number and types of antigen receptor gene rearrangements are observed between common and pre-B immunophenotype within the study and the control group, age-related variations are restricted to the common BCP phenotype in both groups. In the study group, the IGH (OR ¼ 0.8, Po0.01) and TCRD rearrangements (OR ¼ 0.8, Po0.01), and in the control group the IGK-Kde (OR ¼ 1.1, P ¼ 0.01), TCRD (OR ¼ 0.9, P ¼ 0.04), and TCRG rearrangements (OR ¼ 1.1, P ¼ 0.02) are involved.
According to these data, we assume that in leukemic precursor cells with a more immature, that is common BCP, phenotype the potential to recombine the antigen receptor genes is greater the older the children get. The difference in the affected antigen receptor loci between the study and the control group might result from the already higher incidence of recombinations at the IGK-Kde and TCRG locus in the TEL-AML1-positive leukemias compared to the control group.
Low incidence of oligoclonality in TEL-AML1-positive leukemias
Prompted by our earlier results that clonotypic rearrangements may differ between initial diagnosis and relapse of TEL-AML1-positive leukemias and that the relapse clone might be detectable at initial presentation, 32, 33 we evaluated whether subclone formation can frequently be found in these leukemias. To assess the incidence of oligoclonal leukemias by screening PCR, the number of rearrangements per gene locus per ALL was determined (Table 3 ). In contrast to our expectation, the incidence of oligoclonal IGH rearrangements was much lower in the study group compared to the control group, whereas the incidence of oligoclonal antigen receptor rearrangements of the IGK-Kde, TCRD, and TCRG genes did not differ between these two groups ( Table 3) .
The control group consists of leukemias without the most common chromosomal translocations (t(12;21), t(4;11), and t(9;22)), but comprises those with numerical aberrations including hyperdiploid leukemias. According to the general incidence of hyperdiploid ALL in about 30% of BCP ALL with a gain of chromosome 14 in 80% of them, 34 cases that might have three chromosome 14 account for about 50% in our control group. We therefore assume that three IGH rearrangements might -at least in part -reflect rearrangements on all three alleles of the hyperdiploid clone. Therefore, these leukemias appear oligoclonal by our definition but are in fact monoclonal. Indeed, 14 of the 26 control ALL with three IGH rearrangements from which cytogenetic analysis were performed had a hyperdiploid karyotype.
The gene usage of some antigen receptor gene rearrangements of TEL-AML1-positive leukemias shows particular features IGH: Sequences of complete IGH rearrangements from the study (n ¼ 204) and the control (n ¼ 169) groups were used for the analysis of gene family usage. In both groups, the V H 3 gene segment is most frequently used (48 and 46% of cases, respectively), followed by V H 1 (19 and 18%), V H 4 (15 and Figure 2 Frequency of antigen receptor gene rearrangements according to age in (a) TEL-AML1-positive ALL and (b) TEL-AML1-negative leukemias. In order to assess whether any of the leukemia subgroups went through an Ig protein-mediated selection process, we analyzed complete IGH rearrangements for their potential functionality (ie in frame with a maintained triplet codon structure through the CDR3 region and no stop codon) from TEL-AML1-positive common BCP leukemias (n ¼ 23), and common BCP cases of the control group (n ¼ 29; hyperdiploid ALL, n ¼ 14; nonhyperdiploid ALL, n ¼ 15). For the cases with a pre-B phenotype, the presence of an open reading frame (ORF) is assumed because they express CyIgm. In the TEL-AML1 positive, the hyperdiploid and nonhyperdiploid common BCP leukemias 40, 28, and 20% of cases, respectively, have an ORF without a stop codon. Since these common BCP leukemias do not express CyIgm, it can be assumed that the remaining -not analyzed -sequence of the IGH rearrangement is either out of frame, contains a stop, or, has a deletion. 35, 36 Since oligoclonal IGH rearrangements are frequently observed in BCP ALL, 18 a potentially functional IGH sequence in a common BCP leukemia may be derived from a minor CyIgm-positive subclone (o15%). We therefore conclude that neither the study nor the control groups generally undergo an Ig protein-mediated selection process.
IGK-Kde: From 257 IGK-Kde rearrangements in TEL-AML1-positive ALL, 30% are intron RSS-Kde rearrangements, 28% are VkII-Kde, 21% VkI-Kde, 19% VkIII-Kde, and 3% VkIV-Kde rearrangements. In the 109 IGK-Kde rearrangements from control leukemias, VkII (26%), VkI (24%), and intron RSS-Kde (22%) are equally frequently used, followed by VkIV (18%) and VkIII (10%). The difference for intron RSS, VkIII, and for VkIV between TEL-AML1-positive ALL and controls is significant (Po0.01, ¼ 0.03, and o0.01, respectively, w 2 test). Furthermore, there is a trend towards a higher intron RSS usage with increasing age in the study group (Po0.09, w 2 test), whereas the frequency of intron RSS does not change with age in the control group.
TCRD: Analysis of 163 TCRD rearrangements from TEL-AML1-positive ALL and 138 TCRD rearrangements from TEL-AML1-negative ALL revealed no statistical difference in the distribution of the two types of incomplete TCRD rearrangements between both groups, with 80 and 86% Vd2-Dd3 rearrangements and 20 and 14% Dd2-Dd3 rearrangements in the study and the control group, respectively. TCRG: Nucleotide sequence information is available from 260 TCRG rearrangements from TEL-AML1-positive ALL and 145 rearrangements from TEL-AML1-negative ALL. The usage of the Vg families is similar in the study and control groups, with predominance of VgI (63 and 70%, respectively), followed by VgII (36 and 27%) and VgIV (1 and 3%). In neither group, a VgIII rearrangement is detected. In TCRG rearrangements from TEL-AML1-positive and -negative ALL, the Jg1.3/2.3 family is more frequently used (89 and 62%) than the Jg1.1/2.1 (11 and 38%) . The difference in the Jg1.1/2.1 usage between the study and the control group is significant (Po0.001, w 2 test).
Discussion
This comprehensive study of 214 children with TEL-AML1-positive ALL was performed to test our hypothesis that somatic recombination of Ig/TCR genes is influenced by the TEL-AML1 fusion gene. Our data provide first evidence that this assumption is valid since the TEL-AML1-positive ALL have a high number of Ig/TCR rearrangements with a more mature immunogenotype, which differ from those in 174 TEL-AML1-negative childhood BCP ALL. We further demonstrate age-related differences in rearrangements towards higher recombination rates and endstage joints in the older children of the study group. It has been reported previously that the transcription factor AML1 accelerates G1 to S progression in an in vitro model, but fails to activate transcription of AML1 target genes after fusion of AML to TEL. 27, 28 This gene fusion results in cell cycle retardation and thus RAG proteins may be active for a prolonged time. Data on RAG-2 showing its accumulation in G0/G1 and degradation upon transition to S phase 12 support this assumption. If this situation is paralleled in TEL-AML1-positive leukemias, the fusion gene formation, as an early event in leukemogenesis, would retard proliferation, thereby providing optimal conditions for V(D)J recombination. The high incidence of antigen receptor rearrangements with mature and end-stage features in the TEL-AML1-positive ALL as described in this report might be the result of such cell cycle deregulation.
The higher number of antigen receptor gene rearrangements in the TEL-AML1-positive group compared to the control group is due to an increase in predominantly biallelic TCRG and IGK rearrangements. In the majority of cases they represent endstage rearrangements, being VgI family to Jg1.3/2.3 rearrangements and intron RSS-Kde rearrangements, respectively, which are hypothetically derived from ongoing rearrangement processes. The preferential usage of VgI-Jg1.3/2.3 rearrangements in a small number of TEL-AML1-positive ALL was reported recently. 24 In line with the end-stage IGK and TCRG recombinations are the almost exclusively complete IGH rearrangements. The lack of incomplete DJ H rearrangements is not caused by an inaccessibility of the D H segments, since D H regions are involved in VJ H rearrangements as frequently as in the control group, but rather seems to result from efficient rearrangement processes joining a V H segment to each DJ H rearrangement to form a complete joint. Since both alleles of a cell have usually a DJ H rearrangement before the formation of a mature VDJ H rearrangement, the additional finding of monoallelic VDJ H rearrangements in half of the cases suggests that IGH gene deletions occur during ongoing recombinations. In contrast to Southern blot analysis, the presence of such deletions cannot be confirmed by our PCR approach because only gene rearrangements are amplified and no information on germline configuration or deletions is available. We therefore looked at Southern blot data from 10 TEL-AML1-positive leukemias and found a monoallelic IGH gene deletion in five of them. Such partial deletions of IGH genes are present in about 10% of BCP ALL and frequently involve J H , but also V H segments. 14, 36 The dominance of monoallelic TCRD rearrangements over biallelic recombinations in TEL-AML1-positive leukemias can be either explained by germline configuration of the TCRD gene on the second allele, or, more appealing to us, by ongoing recombination. Incomplete TCRD rearrangements (Dd2-Dd3, Vd2-Dd3) are intermediate recombinations that either proceed to mature joints in T cells, or may recombine to one of the Ja segments in BCP cells, thereby deleting the sequences in between, which then are no longer detectable by PCRs for incomplete TCRD rearrangements. Vd2 to Ja recombinations are found in 20-36% of childhood BCP ALL and have also been observed to occur in in vitro cultures of two BCP ALL cell lines, one of which was the TEL-AML1-positive cell line REH. 18, 37 The age of the children at diagnosis seems to influence the incidence of crosslineage TCR rearrangements in BCP ALL with the highest incidence for TCRD and the lowest incidence for TCRG rearrangements in children younger than 2 years. 18, 24 In this study, significant changes related to age were found on all four Ig/TCR genes, which are also influenced by the interaction of TEL-AML1. This results in a reduction of biallelic IGH rearrangements and a decreased incidence of TCRD rearrangements in the study group, an increased incidence of IGK-Kde rearrangements in the control group as well as further changes (ie a decrease in IGH but an increase in TCRG rearrangements) in both groups. Interestingly, age-related changes in both, study and control group, are restricted to the common BCP immunophenotype of the leukemias, while no difference of antigen receptor gene rearrangements is observed between the study and the control group when the immunophenotype (common BCP type vs pre-B phenotype) of the leukemias is considered. These findings confirm earlier reports indicating a relation of crosslineage TCR rearrangements with the maturation stage of the B cells based on the lower frequencies of TCR rearrangements in the more mature CyIgm-positive pre-B-cell group. 18 While changes are reported, so far, only for TCR rearrangements, we here provide evidence that also the lineagespecific Ig genes may be affected by age in the CyIgm-negative common BCP ALL subtype, which suggests a higher potential for variations of the antigen receptor gene rearrangements in the course of time in the more immature leukemia precursor cell. This confirms earlier assumptions that crosslineage rearrangements occur after malignant transformation of the B-precursor cell due to continuing activity of the VDJ recombinase system. 38 The distinct differences in the frequency of antigen receptor gene rearrangements according to age in study vs control leukemias may be due to a generally higher recombination rate in TEL-AML1-positive cases.
In contrast to our assumption that a high recombination rate also leads to increased subclone formation, the overall incidence of oligoclonality, as defined by more than two rearranged PCR products of each antigen receptor gene, was lower in TEL-AML1-positive ALL than in control ALL (20 vs 34%). This difference, however, was exclusively confined to the IGH locus, which is in the reported range of 20-40% of BCP ALL. 14, 39 Although our control group is well defined by negativity for the chromosomal translocations t(12;21), t(4;11), and t(9;22), it comprises a heterogeneous population regarding other cytogenetic aberrations. The largest group are the hyperdiploid leukemias with a general incidence of about 30% in childhood ALL. They are now over-represented in our control group and probably comprise about 50%. Since the majority of hyperdiploid leukemias have one and sometimes, although rarely, also two additional chromosomes14, 34 the chromosome on which the IGH gene is located, it might -at least in part -be possible that leukemias with three or four IGH rearrangements are in fact monoclonal, if we assume that each chromosome has its IGH allele differently rearranged. In support of this possibility is the fact that more than half of the cases with three detectable IGH rearrangements in this control group have a hyperdiploid karyotype. These data could imply that there is probably no difference in oligoclonality between the study and the control group.
As assumed in general for BCP ALL in childhood, 20, 35 the data from this study indicate that the precursor cell of TEL-AML1-positive ALL is not selected prior to malignant transformation. An exception to this has been recently shown to be the t(1;19)-positive ALL. 23 There are only limited analyses of ORF in BCP leukemias indicating that about 30% of the CDR3 regions of clonotypic IGH rearrangements are potentially functional. 20 In contrast to this former study, only three of 33 sequences retained an ORF when the complete rearrangements were considered. In addition, two of these sequences were derived from CyIgmpositive leukemias. 35 The seemingly discrepancy between these two studies may be due to the inclusion of CyIgm-positive cases in the first study, in which no immunophenotype is provided, and/or in the occurrence of mutations or deletions outside the CDR3 regions. 35 Our data are in line with these reports showing 20-40% of potentially functional CRD3 regions within the common CyIgm-negative leukemias of study and control leukemias. Accordingly, these rearrangements may also contain mutations or deletions in the nonsequenced regions, or they may be derived from minor leukemia subclones that are CyIgm positive.
Finally, bringing our data of Ig/TCR rearrangements into the context of the etiology of TEL-AML1-positive leukemias, we postulate that TEL-AML1, as a first or early leukemogenic event, occurs in two-thirds of cases in an immature B cell prior to the production of a functional IGH rearrangement and thereby prevents apoptosis of the affected cell. Thus, the leukemiainitiating event is linked to the time of IGH recombination. The V(D)J recombinase system continues to be active and further recombines Ig/TCR genes. Given the in utero initiation of this type of leukemia, the age-related variations indicate that the longer the preleukemic phase is, that is the older the child at diagnosis, the higher the changes may become. Such changes seem to be more pronounced in the common (CyIgm negative) BCP subgroup, which is probably more prone to a higher potential for recombination. The findings in TEL-AML1-positive leukemias is in accordance with a high recombination activity of all genes resulting in an apparent decrease of IGH and TCRD rearrangements due to joining of TCRD rearrangements to J and deletion of IGH genes and a concomitant increase of rearrangements at the IGK and TCRG level. The general difference to the leukemias in the control group is based on the lower recombination efficiency in the TEL-AML1-negative group. We cannot, however, exclude possible differences within this heterogeneous control group.
In addition to the reported age distribution of children with TEL-AML1-positive ALL predominantly between 1 and 10 years, 4, 5 we found a lower spread of the distribution curve with an age between 3 and 6 years in almost 50% of the children and a rare occurrence in very young children (1-2 years old) and those older than 10 years. This age distribution suggests, together with the in utero origin of the leukemia 10 and the rarity of TEL-AML1-positive leukemias in adults, 40, 41 that this leukemia may be derived from a differentiated stem cell with a limited life expectancy of about 10 years. 42 Ig/TCR rearrangements in TEL-AML1-positive ALL S Hübner et al
We provide in this report new insights into the biology of TEL-AML1-positive leukemia as well as valuable information for minimal residual disease studies using clonotypic antigen receptor rearrangements as targets. The data presented here do, however, not imply any change in strategies for target selection and/or number of targets to be used for the detection of minimal residual disease as currently implemented by the AIEOP-BFM ALL 2000 protocol.
